Quality ratings hit to key Medicare plan shakes Humana stock
The IndependentFor free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ /verifyErrors }} Shares of Humana tumbled Wednesday after the health insurer said a Medicare Advantage quality rating drop will hurt future bonus payments the company receives. That ratings drop could equate to a $1.9 billion revenue hit in 2026 before Humana does anything to offset the blow, Leerink Partners analyst Whit Mayo said in a research note. BTIG analyst David Larsen said in a separate note that Humana's ratings were disappointing given that Medicare Advantage plans already are dealing with challenges like higher claims cost and more inpatient hospital visits.